Orphan Drug Amendments of 1991 : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2060 ... Tuesday, March 3, 1992.

Orphan Drug Amendments of 1992 : report together with additional views (to accompany S. 2060).
Published: (1992)

The Orphan Drug Act : implementation and impact
Published: (2001)

Orphan diseases and orphan drugs
Published: (1986)

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981).
Published: (1994)

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981).
Published: (1994)

Rare diseases and orphan drugs keys to understanding and treating the common diseases
by: Berman, Jules J.
Published: (2014)

Anticompetitive Abuse of the Orphan Drug Act invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Orphan products development : Office of Orphan Products Development.
Published: (1998)

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office).
Published: (1994)

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office).
Published: (1994)

Orphan vaccines : bridging the gap : Palm Cove, Queensland, Australia, 25th-29th August 2001
Published: (2002)

Orphan drug reauthorization hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Expert opinion on orphan drugs
Published: (2013)

Cooperative approaches to research and development of orphan drugs : proceedings of a conference in New York, New York, April 9 and 10, 1984
Published: (1985)

Small market drugs, big price tags :are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)

Rare diseases and orphan products : accelerating research and development
Published: (2010)

Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Orphan drugs
by: Anderson, Kenneth, 1921-2001
Published: (1987)

Orphan Drug Amendments of 1990 : report (to accompany H.R. 4638) (including cost estimate of the Congressional Budget Office).
Published: (1990)

Orphan Drug Amendments of 1990 : report (to accompany H.R. 4638) (including cost estimate of the Congressional Budget Office).
Published: (1990)

[Henry A. Waxman talks about the need for legislation to support research on "orphan drugs", those which could not repay the pharmaceutical research in the open market].
Published: (1983)

Pricing of drugs codeveloped by federal laboratories and private companies hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Orphans : file of clippings and miscellanea.
Published: (1970)

Drug pricing and the law : regulatory exclusivities
by: Ward, Erin H.
Published: (2019)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

The orphan train in Michigan, 1854-1927
Published: (2002)

The orphan trains placing out in America
by: Holt, Marilyn Irvin, 1949-
Published: (1992)